Understand the source comparison
Telomere Lengthening Peptides 2026 Update: Product Comparison
Before diving into specific peptides, this table distills the key structural, mechanistic, and dosing differences between the primary telomere-related compounds under investigation as of the 2026 telomere lengthening peptides update. Epitalon (Ala-Glu-Asp-Gly)
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before diving into specific peptides, this table distills the key structural, mechanistic, and dosing differences between the primary telomere-related compounds under investigation as of the 2026 telomere lengthening peptides update.
- Epitalon (Ala-Glu-Asp-Gly)
- Direct TERT promoter binding, increases transcription 2.5–3.2×
- 10mg SC daily × 10 days
- Strong. Multiple in vitro and Phase II trials show 30–40% activity increase
- Lyophilized at −20°C; reconstituted 2–8°C, 14-day max
- Gold standard for peptide-based telomerase modulation; most replicated data
- Thymalin (thymus peptide complex)
- Immune-cell-specific telomerase activation in T-lymphocytes
- 10mg IM daily × 10 days
- Moderate. T-cell telomere stabilization demonstrated, no systemic effect
- Targeted immune longevity tool; not a systemic telomere intervention
- TA-65 (cycloastragenol)
- Histone deacetylase inhibition at TERT promoter (epigenetic)
- 250–500mg oral daily (continuous)
- Weak. Inconsistent RCT results; observational data shows 2.1% length increase
- Room temperature (oral capsule)
- Small-molecule approach with unclear dose-response; less reliable than Epitalon
- GHRP-2 / Hexarelin
- Indirect via IGF-1 → PI3K/Akt → TERT stabilization
- 100mcg SC twice daily × 3 months
- Weak. Tissue-specific (muscle) effects only; no PBMC telomere change
- Lyophilized at −20°C; reconstituted 2–8°C, 28-day max
- Growth hormone secretagogue with secondary telomere effects; not a primary tool